Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase 1 2Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Head & Neck 1Dermatologic 1

Conditions

Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 5lenvatinib 4Fentanyl 4Morphine 3Fluorouracil 3Docetaxel 3trametinib 2selpercatinib 2pralsetinib 2pembrolizumab 2nimotuzumab 2larotrectinib 2dabrafenib 2cabozantinib 2anlotinib 2Thyrotropin Alfa 2Saline Solution 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Norepinephrine 2Metformin 2Indocyanine Green 2Gabapentin 2Cinacalcet 2Cetuximab 2Carboplatin 2Benzydamine 2Acetaminophen 2xiaojin wan 1vandetanib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Bleomycin × Head & Neck × Clear all
NCT00198263 2017-10-03

Study Using the Medpulser Electroporation System With Bleomycin to Treat Head and Neck Cancer

Inovio Pharmaceuticals

Phase 4 Completed
95 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡